QurAlis has won the Pfizer Golden Ticket! to read more click here.
Read MoreThe man had come for a third opinion. Other doctors had told him he had amyotrophic lateral sclerosis, or ALS, a neuromuscular disease that causes progressive paralysis, but he didn’t…
Read MoreWe successfully generated a crystal structure of one of our early lead molecules in complex with our molecular target. This structure is currently being used to design new compounds.
Read MoreCAMBRIDGE, Mass., April 5, 2018. QurAlis Corporation, a new private biotech company focused on developing precision solutions to cure ALS, today announced the addition of biotech investors MP Healthcare Venture…
Read MoreCAMBRIDGE, Mass., Dec. 15, 2017 QurAlis was chosen by an Amgen internal committee and live audience members at a “Quick Pitch” event hosted by Amgen at its Cambridge R&D and Operations…
Read More